Status:
COMPLETED
Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
Lead Sponsor:
Abbott
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Eligibility Criteria
Inclusion
- Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
- Subject, based on assessment of investigator, meets the definition of active RA
Exclusion
- Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
- Female subject who is pregnant or breast-feeding or considering becoming pregnant
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1938 Patients enrolled
Trial Details
Trial ID
NCT00234897
Start Date
August 1 2004
Last Update
August 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Medical Information - Abbott
North Chicago, Illinois, United States, 60064